Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Igc Pharma, Inc. (ICG) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Igc Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1326205.
Total stock buying since 2017: $0.
Total stock sales since 2017: $1,439,000.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 0 | $0 | 2,071,668 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 983,336 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 1,533,335 | $0 |
| 2021 | 0 | $0 | 150,000 | $284,750 | 0 | $0 |
| 2020 | 0 | $0 | 130,000 | $289,040 | 0 | $0 |
| 2018 | 0 | $0 | 502,020 | $680,414 | 0 | $0 |
| 2017 | 0 | $0 | 229,950 | $184,796 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-03 | 0 | $0 | 0 | $0 | 2,071,668 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 983,336 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 250,000 | $0 |
| 2022-05 | 0 | $0 | 0 | $0 | 750,000 | $0 |
| 2022-03 | 0 | $0 | 0 | $0 | 533,335 | $0 |
| 2021-03 | 0 | $0 | 150,000 | $284,750 | 0 | $0 |
| 2020-12 | 0 | $0 | 50,000 | $102,000 | 0 | $0 |
| 2020-11 | 0 | $0 | 80,000 | $187,040 | 0 | $0 |
| 2018-08 | 0 | $0 | 466,020 | $641,390 | 0 | $0 |
| 2018-01 | 0 | $0 | 36,000 | $39,024 | 0 | $0 |
| 2017-12 | 0 | $0 | 229,950 | $184,796 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-13 | Moran James P | Option Ex | 220,834 | .00 | 0 |
| 2024-03-13 | Grimaldi Claudia | Option Ex | 336,666 | .00 | 0 |
| 2024-03-13 | Prins Richard K | Option Ex | 329,583 | .00 | 0 |
| 2024-03-13 | Mukunda Ram (CEO) | Option Ex | 1,184,585 | .00 | 0 |
| 2023-03-31 | Moran James P | Option Ex | 83,334 | .00 | 0 |
| 2023-03-31 | Grimaldi Claudia (VICE PRESIDENT, CCO & PF0) | Option Ex | 141,667 | .00 | 0 |
| 2023-03-31 | Prins Richard K | Option Ex | 158,334 | .00 | 0 |
| 2023-03-31 | Mukunda Ram (CEO) | Option Ex | 600,001 | .00 | 0 |
| 2022-06-01 | Lynch John Edward | Option Ex | 9,375 | .00 | 0 |
| 2022-06-01 | Grimaldi Claudia (VICE PRESIDENT & PF0) | Option Ex | 9,375 | .00 | 0 |
| 2022-06-01 | Prins Richard K | Option Ex | 31,250 | .00 | 0 |
| 2022-06-01 | Mukunda Ram (CEO) | Option Ex | 200,000 | .00 | 0 |
| 2022-05-31 | Lynch John Edward | Option Ex | 28,125 | .00 | 0 |
| 2022-05-31 | Grimaldi Claudia (VICE PRESIDENT & PF0) | Option Ex | 28,125 | .00 | 0 |
| 2022-05-31 | Prins Richard K | Option Ex | 93,750 | .00 | 0 |
| 2022-05-31 | Mukunda Ram (CEO) | Option Ex | 600,000 | .00 | 0 |
| 2022-03-21 | Grimaldi Claudia (VICE PRESIDENT & PF0) | Option Ex | 83,334 | .00 | 0 |
| 2022-03-21 | Prins Richard K | Option Ex | 100,000 | .00 | 0 |
| 2022-03-21 | Mukunda Ram (CEO) | Option Ex | 350,001 | .00 | 0 |
| 2021-03-09 | Prins Richard K | Sale | 50,000 | 1.75 | 87,500 |
| 2021-03-03 | Prins Richard K | Sale | 50,000 | 1.80 | 90,250 |
| 2021-03-02 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 50,000 | 2.14 | 107,000 |
| 2020-12-01 | Prins Richard K | Sale | 50,000 | 2.04 | 102,000 |
| 2020-11-30 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 80,000 | 2.34 | 187,040 |
| 2018-08-30 | Grimaldi Claudia (Vice President and PFO) | Sale | 116,020 | 2.00 | 232,040 |
| 2018-08-30 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 50,000 | 1.86 | 93,250 |
| 2018-08-28 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 125,000 | 1.33 | 166,000 |
| 2018-08-27 | Grimaldi Claudia (Vice President and PFO) | Sale | 50,000 | 1.10 | 55,000 |
| 2018-08-27 | Prins Richard K | Sale | 50,000 | 1.08 | 54,000 |
| 2018-08-24 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 25,000 | .64 | 16,000 |
| 2018-08-22 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 50,000 | .50 | 25,100 |
| 2018-01-12 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 12,000 | 1.05 | 12,600 |
| 2018-01-11 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 12,000 | 1.11 | 13,380 |
| 2018-01-10 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 12,000 | 1.09 | 13,044 |
| 2017-12-15 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 25,000 | .76 | 19,000 |
| 2017-12-14 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 25,000 | .75 | 18,750 |
| 2017-12-08 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 54,950 | .87 | 47,696 |
| 2017-12-07 | Mukunda Ram (Exec. Chairman & CEO) | Sale | 100,000 | .85 | 85,500 |
| 2017-12-04 | Prins Richard K | Sale | 25,000 | .55 | 13,850 |
Insider trading activities including stock purchases, stock sales, and option exercises of ICG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Igc Pharma, Inc. (symbol ICG, CIK number 1326205) see the Securities and Exchange Commission (SEC) website.